奥精医疗
(688613)
| 流通市值：22.11亿 | | | 总市值：22.11亿 |
| 流通股本：1.36亿 | | | 总股本：1.36亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 148,311,250.58 | 100,240,888.1 | 47,360,874.94 | 226,475,894.98 |
| 营业收入 | 148,311,250.58 | 100,240,888.1 | 47,360,874.94 | 226,475,894.98 |
| 二、营业总成本 | 155,366,595.73 | 102,413,305.12 | 45,835,228.75 | 210,454,698.07 |
| 营业成本 | 37,883,215.86 | 23,320,799.07 | 9,294,056.29 | 39,237,341.56 |
| 税金及附加 | 2,605,581.75 | 1,844,526 | 859,947.53 | 3,787,689.78 |
| 销售费用 | 29,413,832.57 | 20,121,171.11 | 9,480,406.89 | 37,692,658.78 |
| 管理费用 | 61,832,042.95 | 41,847,177.06 | 18,169,296.39 | 84,349,702.21 |
| 研发费用 | 24,366,528.85 | 16,732,657.88 | 7,554,567.39 | 45,504,233.46 |
| 财务费用 | -734,606.25 | -1,453,026 | 476,954.26 | -116,927.72 |
| 其中:利息费用 | 2,169,411 | 1,455,422.98 | - | 3,128,449.33 |
| 其中:利息收入 | -3,126,124.85 | -3,084,110.44 | - | 3,265,080.12 |
| 加:公允价值变动收益 | 2,543,421.55 | 8,109,817.61 | 4,202,574.84 | 15,100,223.34 |
| 加:投资收益 | 13,606,668.52 | 411,537.05 | - | 2,917,676.01 |
| 资产处置收益 | 643,911.25 | 747,528.78 | -3,703.2 | -588,939.38 |
| 信用减值损失(新) | -2,097,027.55 | -2,105,863.27 | - | -1,416,829.57 |
| 其他收益 | 293,569.96 | 289,634.16 | 85,866.16 | 16,961,011.18 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 7,935,198.58 | 5,280,237.31 | 5,810,383.99 | 48,994,338.49 |
| 加:营业外收入 | 0.94 | 0.94 | - | 193,308.45 |
| 减:营业外支出 | 1,501,035.66 | 164,910.93 | 164,845.92 | 93,149.37 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 6,434,163.86 | 5,115,327.32 | 5,645,538.07 | 49,094,497.57 |
| 减:所得税费用 | 7,244,663.64 | 172,318.28 | 256,293.51 | -3,871,977.67 |
| 六、净利润 | -810,499.78 | 4,943,009.04 | 5,389,244.56 | 52,966,475.24 |
| 持续经营净利润 | -810,499.78 | 4,943,009.04 | 5,389,244.56 | 52,966,475.24 |
| 归属于母公司股东的净利润 | 4,888,240.36 | 9,222,057.43 | 6,938,107.45 | 54,231,840.71 |
| 少数股东损益 | -5,698,740.14 | -4,279,048.39 | -1,548,862.89 | -1,265,365.47 |
| (一)基本每股收益 | 0.04 | 0.07 | 0.05 | 0.41 |
| (二)稀释每股收益 | 0.04 | 0.07 | 0.05 | 0.41 |
| 八、其他综合收益 | 25,125.05 | -3,814.7 | - | -228,313.54 |
| 归属于母公司股东的其他综合收益 | 25,125.05 | -3,814.7 | - | -228,313.54 |
| 九、综合收益总额 | -785,374.73 | 4,939,194.34 | 5,389,244.56 | 52,738,161.7 |
| 归属于母公司股东的综合收益总额 | 4,913,365.41 | 9,218,242.73 | 6,938,107.45 | 54,003,527.17 |
| 归属于少数股东的综合收益总额 | -5,698,740.14 | -4,279,048.39 | -1,548,862.89 | -1,265,365.47 |
| 公告日期 | 2024-10-29 | 2024-08-27 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |